Pharma & Biotech News #PharmaBuzz
India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn
Impressions : 111
Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses
Impressions : 1329
FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development
Impressions : 2092
Hainan's Generics Tigecycline Receives Tentative Approval in US
23 Apr 2026 //
FDA
Anthea Pharma's Generics Bupivacaine HCl Receives Approval in US
22 Apr 2026 //
FDA
Shuangcheng's Generics Pantoprazole Na Receives Approval in US
22 Apr 2026 //
FDA
Omsav Pharma's Generics Flecainide Receives Approval in US
22 Apr 2026 //
FDA
Micro's Generics Escitalopram Oxalate Receives Approval in US
22 Apr 2026 //
FDA
Laurus's Generics Valsartan Receives Approval in US
21 Apr 2026 //
FDA
Apotex's Generics Multiple Vitamins Inj Receives Approval in US
21 Apr 2026 //
FDA
Torrent's Generics Vericiguat Receives Tentative Approval in US
20 Apr 2026 //
FDA
Merck Sharp And Dohme's Idvynso Receives Approval in US
20 Apr 2026 //
FDA
Sandoz's Generics Enzalutamide Receives Approval in US
20 Apr 2026 //
FDA
Enforcement Report - Week of April 22, 2026
22 Apr 2026 //
FDA
Veyx-Pharma B.V. Production Fails EDQM Inspection
21 Apr 2026 //
EMA
Produlab Pharma Production Fails EDQM Inspection
21 Apr 2026 //
EMA
Thrive Health and Wellness' Receives FDA Warning Letter
21 Apr 2026 //
FDA
Xiamen Kang Zhongyuan Biotechnology's Receives FDA Warning Letter
21 Apr 2026 //
FDA
Apollo Care's Receives FDA Warning Letter
21 Apr 2026 //
FDA
UCSF Radiopharmaceutical Facility's Receives FDA Warning Letter
21 Apr 2026 //
FDA
RC Outsourcing's Receives FDA Warning Letter
21 Apr 2026 //
FDA
Par Health's Receives FDA Warning Letter
21 Apr 2026 //
FDA
Cabio Biotech Wuhan is on FDA Import Alert List
20 Apr 2026 //
FDA
Biogen Targets Patients Transitioning Off Lilly's Kisunla
30 Apr 2026 //
BIOSPACE
AbbVie Reports First-Quarter 2026 Financial Results
30 Apr 2026 //
PRESS RELEASE
Chiesi Snaps Up Kalvista For $1.9B, Betting Big On Rare Disease
30 Apr 2026 //
BIOSPACE
Dr Reddy's Laboratories Receives Approval From Health Canada
30 Apr 2026 //
ECONOMICTIMES
FDA, AstraZeneca prep for oncology adcomm
30 Apr 2026 //
ENDPOINTS
Granules India Q4FY26 revenue jumps 23% to Rs 14,706 million
30 Apr 2026 //
INDPHARMAPOST
Revolution Issues Legal Threat to Erasca as Rivalry Heats
30 Apr 2026 //
BIOSPACE
Emergent, Substipharm Partner on JE Vaccine Manufacturing
30 Apr 2026 //
GLOBENEWSWIRE
Boehringer, Zealand's Obesity Drug Resembles Novo's Wegovy
30 Apr 2026 //
BIOSPACE
Vitalhub Announces Q1 2026 Conference Call Date
29 Apr 2026 //
GLOBENEWSWIRE
Dr Reddy's Laboratories Receives Approval From Health Canada
30 Apr 2026 //
ECONOMICTIMES
Pfizer Secures Deals to Block Heart Drug Generics Until 2030
28 Apr 2026 //
REUTERS
Hikma And Amarin's Generic Drug Case Goes To Supreme Court
28 Apr 2026 //
ENDPOINTS
Novartis Reports Earnings Miss Due To Generic Competition
28 Apr 2026 //
REUTERS
Pfizer Delays Patent Cliff For Blockbuster Vyndamax
28 Apr 2026 //
ENDPOINTS
Supreme Court to consider skinny labeling case
28 Apr 2026 //
RAPS
Alembic Announces FDA Final Approval For Fingolimod Capsules
27 Apr 2026 //
INDPHARMAPOST
Sun Pharma signs Definitive Agreement to Acquire Organon
27 Apr 2026 //
BUSINESSWIRE
Cipla's generic Ventolin HFA secures USFDA approval
24 Apr 2026 //
INDPHARMAPOST
Novartis' Lutathera Radioligand Therapy Faces Generic Rivals
23 Apr 2026 //
ENDPOINTS
Biogen Targets Patients Transitioning Off Lilly's Kisunla
30 Apr 2026 //
BIOSPACE
FDA, AstraZeneca prep for oncology adcomm
30 Apr 2026 //
ENDPOINTS
Revolution Issues Legal Threat to Erasca as Rivalry Heats
30 Apr 2026 //
BIOSPACE
Emergent, Substipharm Partner on JE Vaccine Manufacturing
30 Apr 2026 //
GLOBENEWSWIRE
Boehringer, Zealand's Obesity Drug Resembles Novo's Wegovy
30 Apr 2026 //
BIOSPACE
Mindbio Files Patent Applications In 15 World Firsts
29 Apr 2026 //
GLOBENEWSWIRE
Counterx Therapeutics Invited To Present At Science2Startup
29 Apr 2026 //
PR NEWSWIRE BIO
Codexis To Share RNA Manufacturing Advances At TIDES USA
29 Apr 2026 //
GLOBENEWSWIRE
Vanda Pharma Publishes Imsidolimab GPP Study in NEJM Evidence
29 Apr 2026 //
PR NEWSWIRE
Oxford, Serum Institute Ink New Malaria Vaccine Pact
29 Apr 2026 //
ECONOMICTIMES
Onco-Innovations Scales Up API Materials for PNKP Program
28 Apr 2026 //
PHARMIWEB
C-Ray Receives FDA Acceptance of Type2 DMF for Copper-64 (Cu-64)
28 Apr 2026 //
PR NEWSWIRE
Akums Launches Aztreonam-Avibactam to Fight Resistant Infections
28 Apr 2026 //
EXPRESSPHARMA
Chinese API Surge Strains Indian Pharma Amid Mideast Crisis
24 Apr 2026 //
BUSINESS STD
MiKART, Benuvia Partner for Controlled Drug Solutions
23 Apr 2026 //
PR NEWSWIRE
Supriya Lifescience Gets USFDA EIR For Lote Parshuram Site
22 Apr 2026 //
EXPRESSPHARMA
Rusan Pharma secure Japan PMDA GMP approval for API, FDF facility
20 Apr 2026 //
INDPHARMAPOST
Iran War Impact: Essential Drugs May Cost Up To 5% More, For Now
15 Apr 2026 //
ECONOMICTIMES
SQ Innovation And FIS Strike Supply Deal For Furosemide API
15 Apr 2026 //
PR NEWSWIRE
FDA Accepts NorthStar's DMF for No-Carrier-Added AC-225
15 Apr 2026 //
PHARMIWEB
FDA Risk Management Biggest Hurdle For Inspections Under QMSR
28 Apr 2026 //
RAPS
Gujarat Government Bolsters Drug And Cosmetics Regulation
28 Apr 2026 //
PHARMABIZ
B. Braun Recalls Lactated Ringer's Injection, 1L
28 Apr 2026 //
FIRSTWORD PHARMA
Britain's Lifetime Smoking Ban Set To Become Law
27 Apr 2026 //
REUTERS
FDA Offers Tips On Verifying, Validating Manufacturing Processes
24 Apr 2026 //
RAPS
Probe Urged As Badlapur Fertility Injection Scam Unveiled
23 Apr 2026 //
PHARMABIZ
Pharma Files Citizen Petition Against Fda Rejection Letters
23 Apr 2026 //
BIOSPACE
Citizen Petition Calls On FDA To Tighten Up CRL Disclosures
23 Apr 2026 //
FIERCE PHARMA
FDA Addresses Resourcing Issues Amid Rise In 2025 Class I Recalls
23 Apr 2026 //
RAPS
Omega Pharma Ltd Recalls Napralief 250Mg Gastro-Resistant Tablets
23 Apr 2026 //
FIRSTWORD PHARMA
Medical Devices Industry Hails India-New Zealand FTA
29 Apr 2026 //
PHARMABIZ
Altitude Labs Serves Up Higher Education For Biotech Founders
29 Apr 2026 //
BIOSPACE
OMRON Healthcare Donates 3,000 Bp Monitors Worldwide
28 Apr 2026 //
INDPHARMAPOST
Cynet Enhances CyAI Engine With Self-Improving Features
28 Apr 2026 //
GLOBENEWSWIRE
VivoSim AI Predicts Diarrhea Risk Without Animal Testing
28 Apr 2026 //
GLOBENEWSWIRE
Dr. Denaesh Ariyanayagam Urges Enhanced Patient Advocacy
28 Apr 2026 //
ACCESSWIRE
Prodeon Medical Showcases Urocross Expander System Results
28 Apr 2026 //
GLOBENEWSWIRE
NatureCell Launches FDA-Cleared Phase 2b Alzheimer's Trial
28 Apr 2026 //
ACCESSWIRE
Holivita Introduces Human-Centric Health Platform Using AI
28 Apr 2026 //
GLOBENEWSWIRE
Essilorluxottica Secures FDA Approval For Essilor Stellest
28 Apr 2026 //
INDPHARMAPOST
Chiesi Snaps Up Kalvista For $1.9B, Betting Big On Rare Disease
30 Apr 2026 //
BIOSPACE
Remepy Collaborates With Merck KGaA To Advance Hybrid Drugs
28 Apr 2026 //
PR NEWSWIRE
Soligenix Reports Interim Phase 3 FLASH2 HyBryte Results
28 Apr 2026 //
PR NEWSWIRE
Santhera Reveals AIFA Board Approval For Agamree Reimbursement
28 Apr 2026 //
GLOBENEWSWIRE
Rocket Pharma Announces $180 M Sale of Priority Review Voucher
28 Apr 2026 //
PHARMIWEB
Solid Biosciences Receives EU Orphan Drug Status For SGT-003
28 Apr 2026 //
GLOBENEWSWIRE
Pantherx Rare Pharma Wins 2026 MMIT Patient Choice Award
28 Apr 2026 //
PR NEWSWIRE
BRC Therapeutics Clears FDA For BRC-002 IND Application
28 Apr 2026 //
PR NEWSWIRE
FDA Proposes to withdraw Amgen's drug for Rare Autoimmune Disease
27 Apr 2026 //
REUTERS
Prasad's FDA Exit Aids Rare Diseases; New CBER Head Restores
24 Apr 2026 //
BIOSPACE
AbbVie Reports First-Quarter 2026 Financial Results
30 Apr 2026 //
PRESS RELEASE
Granules India Q4FY26 revenue jumps 23% to Rs 14,706 million
30 Apr 2026 //
INDPHARMAPOST
Vitalhub Announces Q1 2026 Conference Call Date
29 Apr 2026 //
GLOBENEWSWIRE
Teladoc Health Reports First Quarter 2026 Results
29 Apr 2026 //
GLOBENEWSWIRE
Sight Sciences To Present At Two Upcoming Investor Conferences
29 Apr 2026 //
GLOBENEWSWIRE
Regeneron Beats Quarterly Estimates On Strong Dupixent Demand
29 Apr 2026 //
REUTERS HEALTHCARE
Pulmonx Reports First Quarter 2026 Financial Results
29 Apr 2026 //
FIRSTWORD PHARMA
PROCEPT Biorobotics Reports First Quarter 2026 Financial Results
29 Apr 2026 //
GLOBENEWSWIRE
Pharmascience Canada Announces The Launch Of Prpms-Dolutegravir
29 Apr 2026 //
FIRSTWORD PHARMA
Pfizer's Blood Cancer Drug Meets Main Goal In Late-Stage Trial
29 Apr 2026 //
REUTERS HEALTHCARE

